Article

Actigraphy scoring reliability in the study of osteoporotic fractures.

San Francisco Coordinating Center and California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA.
Sleep (Impact Factor: 5.06). 12/2005; 28(12):1599-605.
Source: PubMed

ABSTRACT The editing and scoring of actigraphy data are important for calculating variables that describe sleep. Scoring is dependent on marking time points for when a participant got in and out of bed, plus time when the actigraph was removed. This placement of time points is subject to error. We examined interscorer reliability to determine if files scored by 2 different people were comparable.
Observational study.
Community-based.
A subset of 36 women taken from the latest biannual visit of the Study of Osteoporotic Fractures. All women had actigraphy data scored by 1 scorer for the Study of Osteoporotic Fractures staff, plus a blinded rescoring by an expert scorer at a different site.
N/A.
The outcomes of interest from actigraphy are duration of in-bed interval, total sleep time, sleep latency, sleep efficiency, wake after sleep onset, total nap time, and total daytime minutes of watch removal. Clearly documented actigraphy scoring procedures were used. There were no significant differences between the expert scorer and the study scorer in sleep outcomes (all P values >.16 from a paired t test). There was a small but statistically significant difference between scorers for watch removal times (mean absolute difference 3.4 minutes +/- 5.4, P=.02). The intraclass correlation coefficients showed a high level of agreement (range, 0.84-0.99).
Even in a large study with 2 scorers, it is possible to use actigraphy as a measure of sleep without introducing interscorer measurement error. Using well-documented scoring and data-gathering procedures are essential for data quality control.

Download full-text

Full-text

Available from: Sonia Ancoli-Israel, Jul 02, 2015
0 Followers
 · 
119 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study examined the association between race/ethnicity and objectively measured sleep characteristics in a large sample of older men. Black men had significantly shorter total sleep time (6.1 hr vs. 6.4 hr), longer sleep latency (28.7 min vs. 21.9 min), lower sleep efficiency (80.6% vs. 83.4%), and less slow-wave sleep (4.9% vs. 8.8%) than White men, even after controlling for social status, comorbidities, body mass index, and sleep-disordered breathing. Hispanic men slept longer (6.7 hr) at night than Black (6.1 hr) and Asian American men (6.1 hr). This study supports significant variations in sleep characteristics in older men by race/ethnicity.
    Behavioral Sleep Medicine 12/2011; 10(1):54-69. DOI:10.1080/15402002.2012.636276 · 1.56 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the association between use of selective serotonin reuptake inhibitors (SSRIs) and objective measures of sleep disturbances in older community-dwelling women, including women without evidence of depression. Cross-sectional study. Four U.S. clinical centers. Two thousand eight hundred fifty-three women aged 71 and older (2,630 nonusers of antidepressants and 223 taking SSRIs alone, not in combination with other antidepressants). Medication use, assessed using an interviewer-administered questionnaire with verification of use from medication containers and computerized dictionary used to categorize type of medication; evidence of depression assessed using self-report or a score of 6 or higher on the Geriatric Depression Scale; and sleep parameters measured using a wrist actigraph, with data collected for an average of four consecutive 24-hour periods. Of the overall cohort of 2,853 women and of 2,337 women without evidence of depression, sleep disturbances were more common in women taking SSRIs than in those not taking antidepressants. After excluding women with evidence of depression and adjusting for multiple potential confounders, women taking SSRIs were more likely to have a sleep duration of 5 hours or less (multivariate odds ratio (MOR)=2.15, 95% confidence interval (CI)=1.04-4.47), sleep efficiency less than 70% (MOR=2.37, 95% CI=1.32-4.25), sleep latency of 1 hour or more (MOR=3.99, 95% CI=2.29-6.96) and eight or more long wake episodes (MOR=1.75, 95% CI=0.99-3.10). SSRI use by older women, including those without evidence of depression, is associated with a greater likelihood of sleep disturbances, including poorer sleep efficiency, longer sleep latency, and sleep fragmentation, manifested by multiple long wake episodes. These results add to the uncertainty regarding risks and benefits of SSRI use in aged populations.
    Journal of the American Geriatrics Society 11/2006; 54(10):1508-15. DOI:10.1111/j.1532-5415.2006.00880.x · 4.22 Impact Factor